Acceptance of a Future Gonorrhea Vaccine in a Post-Coronavirus Disease 2019 World: Impact of Type of Recommendation and Changing Levels of Trust in Health Institutions and Authorities

Med Clin North Am. 2023 Nov;107(6S):e19-e37. doi: 10.1016/j.mcna.2023.06.010. Epub 2023 Jun 13.

Abstract

Widespread uptake of a future gonorrhea vaccine could decrease the burden of disease and limit the spread of antibiotic resistance. However, gonorrhea vaccination will occur in the backdrop of the roll-out of the coronavirus disease 2019 (COVID-19) vaccine, which could have influenced parental perceptions about other, non-COVID-19 vaccines. In an internet-based cross-sectional survey, 74% of parents would get a gonorrhea vaccine for their child, and this was higher among those whose trust in pharmaceutical companies increased since the start of the COVID-19 pandemic. About 60% of adults aged 18 to 45 would receive a vaccine for themselves.

Keywords: Gonorrhea; Sexual and gender minorities; Sexually transmitted diseases; Trust; Vaccine hesitancy; Vaccine-preventable disease.

Publication types

  • Review

MeSH terms

  • Adult
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Child
  • Cross-Sectional Studies
  • Gonorrhea* / epidemiology
  • Gonorrhea* / prevention & control
  • Humans
  • Pandemics / prevention & control
  • Trust
  • Vaccines*

Substances

  • Vaccines